Business Context and Reporting Period
This Form 8-K is filed by Landec Corporation (not Lifecore Biomedical, Inc., as indicated in the metadata) on September 29, 2015. The report announces the consolidated financial results for the first quarter of fiscal year 2016, which ended on August 30, 2015.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These details are contained within the press release furnished as Exhibit 99.1, which is referenced but not included in the provided text.
Material Changes
The filing text does not disclose specific material changes versus the prior comparable period. It serves only as a notification that the results have been issued.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, guidance, outlook, risks, contingencies, or unusual items. It explicitly states that the information in the press release (Exhibit 99.1) is furnished and shall not be deemed "filed" for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Verify the specific financial figures (revenue, net income, EPS) in the press release attached as Exhibit 99.1.
- Confirm the discrepancy between the metadata company name (Lifecore Biomedical, Inc.) and the actual registrant (Landec Corporation).
- Review the full press release for any forward-looking statements or risk factors not summarized in this 8-K.